Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Entasis Therapeutics Holdings Inc. - Common Stock (NQ:ETTX)

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, Jul 8, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Entasis Therapeutics Holdings Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022
Six abstracts selected for presentation, including three oral presentations 
From Entasis Therapeutics Holdings Inc.
Via GlobeNewswire
News headline image
Over $42 Million Bet On This Biotechnology Stock? 4 Penny Stocks Insiders are Buying ↗
US producer prices likely to rise 0.8% on the month in June to match the previous month’s growth. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.
From Innoviva, Inc.
Via Business Wire
News headline image
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share ↗
 
Via Benzinga
News headline image
Scott+Scott Attorneys at Law LLP Investigates Innoviva Buyout of Entasis – ETTX
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
58 Biggest Movers From Yesterday ↗
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million. 
Via Benzinga
News headline image
ENTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Entasis Therapeutics Holdings Inc. - ETTX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
ETTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Entasis Therapeutics Holdings Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
News headline image
Innoviva to Acquire Entasis Therapeutics
From Innoviva, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022 ↗
Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading... 
Via Benzinga
News headline image
Entasis Therapeutics Hldg: Q1 Earnings Insights ↗
Entasis Therapeutics Hldg (NASDAQ:ETTX) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Wednesday Top Stock News: 8 Analyst Upgrades and Downgrades Today ↗
We're taking a look at the top stock news for Wednesday and that includes the latest analysts upgrades and downgrades you need to know about! 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022 ↗
Upgrades Bernstein upgraded the previous rating for Stryker Corp (NYSE:SYK) from Market Perform to Outperform. For the fourth quarter, Stryker had an EPS of $2.71, compared to... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022 ↗
Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022 ↗
Upgrades According to Susquehanna, the prior rating for Knight-Swift Transportation Holdings Inc (NYSE:KNX) was changed from Neutral to Positive. Knight-Swift earned $1.61 in the... 
Via Benzinga
News headline image
Recap: Entasis Therapeutics Q4 Earnings ↗
Entasis Therapeutics Hldg (NASDAQ:ETTX) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:30 AM. Here's what investors need to know about the... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Epizyme (NASDAQ:EPZM) stock increased by 14.2% to $1.41 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 9.6... 
Via Benzinga
News headline image
54 Biggest Movers From Yesterday ↗
Gainers MDJM Ltd (NASDAQ: MDJH) shares surged 35.6% to close at $2.44 on Wednesday after gaining 10% on Tuesday. GWG Holdings, Inc. (NASDAQ: GWGH) gained 31.6% to settle at $4.50... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Pharming (NASDAQ:PHAR) shares increased by 15.8% to $10.21 during Wednesday's pre-market session. The company's market cap stands at $652.2 million.... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Good morning, investor! We're beginning another busy day of trading with a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
News headline image
30 Stocks Moving in Friday's Pre-Market Session ↗
Gainers DBV Technologies S.A. (NASDAQ: DBVT) rose 20.3% to $3.68 in pre-market trading after declining 15% on Thursday. DBV Technologies, disclosed that on Oct. 14, it received... 
Via Benzinga
News headline image
Week In Review: China's Hansoh Signs Two siRNA Deals Worth $1.7 Billion ↗
Hansoh announced a $1.3 billion deal to develop three siRNA candidates from London's Silence Therapeutics. In the past week, Hansoh also revealed a $456 million deal with Korea's OliX Pharma for China... 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Nutriband (NASDAQ:NTRB) shares rose 15.52% to $6.72 during Friday's pre-market session. The market value of their outstanding shares is at $49.8 million. T2... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers F-star Therapeutics (NASDAQ:FSTX) shares increased by 18.74% to $7.6 during Wednesday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
News headline image
16 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Troika Media Group, Inc. (NASDAQ: TRKA) rose 27.3% to $2.05 in pre-market trading after surging around 9% on Tuesday. The company, last month, said it swung to a loss in... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Sesen Bio (NASDAQ:SESN) stock mo... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Entasis Announces Positive Data For Late-Stage Study Of SUL-DUR In... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market session. The company's market cap stands at $... 
Via Benzinga
News headline image
Entasis Shares Rally On Positive Data From Drug-Resistant Bacterial Infection Candidate ↗
Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) announced topline results from its Phase 3 ATTACK trial of sulbactam-durlobactam (SUL-DUR) versus colistin in... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.